Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
169 | BMC pharmacology & toxicology | journal | 43 | 21 | 0 | 746 | 0 | 0 | 0.00 | 35.52 | ||
168 | Chemical Speciation and Bioavailability | journal | 0.281 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
167 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | ||
166 | Emerging Microbes and Infections | journal | 94 | 30 | 0 | 1498 | 0 | 0 | 0.00 | 49.93 | ||
165 | F1000Research | journal | 105 | 47 | 0 | 1266 | 0 | 0 | 0.00 | 26.94 | ||
164 | Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment | journal | 0.906 Q2 | 65 | 31 | 41 | 971 | 64 | 37 | 0.00 | 31.32 | |
163 | Journal of Clinical Research | journal | 0.111 Q4 | 12 | 0 | 2 | 0 | 0 | 2 | 0.00 | 0.00 | |
162 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 0 | 71 | 0 | 0 | 65 | 0.00 | 0.00 | |
161 | MedChemComm | journal | 1.042 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
160 | Next Generation Pharmaceutical | trade journal | 0.118 Q4 | 1 | 0 | 221 | 0 | 1 | 132 | 0.00 | 0.00 | |
159 | Pharmaceutical patent analyst | journal | 20 | 42 | 0 | 442 | 0 | 0 | 0.00 | 10.52 | ||
158 | PharmacoVigilance Review | journal | 0.101 Q4 | 2 | 20 | 46 | 70 | 0 | 31 | 0.00 | 3.50 | |
157 | Pharmacy in Practice | journal | 0.101 Q4 | 6 | 0 | 26 | 0 | 0 | 23 | 0.00 | 0.00 | |
156 | Sp2 | trade journal | 0.100 Q4 | 2 | 21 | 189 | 24 | 0 | 169 | 0.00 | 1.14 | |
155 | Toxicology Research | journal | 47 | 23 | 0 | 1605 | 0 | 0 | 0.00 | 69.78 | ||
154 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 65 | 200 | 163 | 1 | 198 | 0.01 | 2.51 | |
153 | Pharmaceutical Journal | journal | 0.131 Q4 | 28 | 795 | 2548 | 360 | 41 | 833 | 0.01 | 0.45 | |
152 | Pharmacy News | journal | 0.102 Q4 | 1 | 0 | 342 | 0 | 2 | 155 | 0.01 | 0.00 | |
151 | Manufacturing Chemist | trade journal | 0.102 Q4 | 6 | 135 | 295 | 306 | 6 | 268 | 0.02 | 2.27 | |
150 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 64 | 215 | 92 | 3 | 213 | 0.02 | 1.44 | |
149 | EBR - European Biopharmaceutical Review | journal | 0.102 Q4 | 6 | 61 | 178 | 401 | 6 | 177 | 0.03 | 6.57 | |
148 | Innovations in Pharmaceutical Technology | trade journal | 0.105 Q4 | 9 | 17 | 151 | 79 | 14 | 144 | 0.05 | 4.65 | |
147 | GMP Review | trade journal | 0.101 Q4 | 2 | 23 | 17 | 87 | 1 | 17 | 0.06 | 3.78 | |
146 | RSC Drug Discovery Series | book series | 0.133 Q4 | 13 | 0 | 28 | 0 | 2 | 11 | 0.07 | 0.00 | |
145 | Quality Assurance Journal | journal | 0.108 Q4 | 11 | 0 | 45 | 0 | 9 | 40 | 0.08 | 0.00 | |
144 | Industrial Pharmacy | trade journal | 0.111 Q4 | 5 | 21 | 19 | 156 | 2 | 19 | 0.11 | 7.43 | |
143 | Regulatory Rapporteur | trade journal | 0.211 Q2 | 7 | 77 | 135 | 410 | 16 | 101 | 0.12 | 5.32 | |
142 | ONdrugDelivery | trade journal | 0.152 Q3 | 7 | 46 | 86 | 120 | 13 | 75 | 0.15 | 2.61 | |
141 | Journal of Biologically Active Products from Nature | journal | 18 | 45 | 37 | 1587 | 6 | 37 | 0.16 | 35.27 | ||
140 | Drug Discovery World | journal | 0.133 Q4 | 14 | 42 | 147 | 503 | 34 | 132 | 0.22 | 11.98 | |
139 | European Pharmaceutical Review | trade journal | 0.124 Q3 | 9 | 49 | 102 | 968 | 20 | 94 | 0.22 | 19.76 | |
138 | Journal of Applied Therapeutic Research | journal | 0.138 Q4 | 8 | 5 | 30 | 206 | 8 | 30 | 0.25 | 41.20 | |
137 | Journal of Generic Medicines (discontinued) | journal | 0.208 Q3 | 16 | 29 | 111 | 224 | 33 | 97 | 0.25 | 7.72 | |
136 | Journal of Pharmaceutical Policy and Practice | journal | 0.164 Q3 | 32 | 15 | 33 | 439 | 9 | 24 | 0.27 | 29.27 | |
135 | Autonomic and Autacoid Pharmacology | journal | 0.238 Q3 | 24 | 7 | 49 | 265 | 34 | 49 | 0.31 | 37.86 | |
134 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.215 Q3 | 7 | 25 | 34 | 349 | 11 | 27 | 0.32 | 13.96 | |
133 | Statistics in Biopharmaceutical Research | journal | 0.247 Q2 | 25 | 37 | 50 | 758 | 19 | 49 | 0.38 | 20.49 | |
132 | International Journal of Computational Biology and Drug Design | journal | 0.157 Q4 | 16 | 23 | 77 | 585 | 31 | 72 | 0.40 | 25.43 | |
131 | Journal of Pharmaceutical Health Services Research | journal | 0.178 Q3 | 19 | 36 | 64 | 918 | 29 | 56 | 0.45 | 25.50 | |
130 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.257 Q4 | 41 | 67 | 209 | 1835 | 114 | 184 | 0.56 | 27.39 | |
129 | Pharmaceutical Medicine | journal | 0.206 Q3 | 25 | 26 | 92 | 724 | 45 | 57 | 0.61 | 27.85 | |
128 | International Journal of Pharmacy Practice | journal | 0.314 Q2 | 44 | 62 | 244 | 1664 | 177 | 221 | 0.63 | 26.84 | |
127 | Drug Discovery Today: Disease Models | journal | 0.228 Q3 | 33 | 33 | 65 | 1830 | 44 | 56 | 0.67 | 55.45 | |
126 | Drug Discovery Today: Therapeutic Strategies | journal | 0.627 Q2 | 31 | 27 | 57 | 1299 | 59 | 49 | 0.71 | 48.11 | |
125 | Environmental Pollutants and Bioavailability | journal | 39 | 31 | 88 | 1298 | 52 | 88 | 0.72 | 41.87 | ||
124 | Issues in Toxicology | book series | 0.195 Q3 | 18 | 72 | 68 | 6768 | 52 | 64 | 0.72 | 94.00 | |
123 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.348 Q3 | 54 | 87 | 377 | 2089 | 300 | 375 | 0.72 | 24.01 | |
122 | HIV Therapy | journal | 0.371 Q3 | 14 | 0 | 108 | 0 | 70 | 79 | 0.77 | 0.00 | |
121 | ATLA Alternatives to Laboratory Animals | journal | 0.330 Q3 | 65 | 57 | 269 | 1049 | 279 | 228 | 0.82 | 18.40 | |
120 | Food Additives and Contaminants: Part B Surveillance | journal | 0.459 Q3 | 41 | 49 | 109 | 1271 | 137 | 108 | 0.93 | 25.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®